2hon MSN
The new weight loss drug offers promising results for those who are overweight or obese. Learn about how Zepbound works, its ...
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research ...
Scientists have discovered an antibody treatment that may help prevent both muscle loss and bone density loss in people using ...
Trump directed a panel headed by HHS Secretary Robert F. Kennedy Jr. to assess “the prevalence of and threat” posed by SSRIs, ...
Novo Nordisk has been looking to diversify its lineup in recent years, and is developing medicines in other fields. The ...
Denise Austin's SI Swimsuit model daughter is 'all for' Ozempic but 'personally would never take it'
Swimsuit Illustrated Sports Issue model and Denise Austin's daughter, Katie Austin, explained why she will never take Ozempic.
Here are 5 of CFRA analysts' top growth stocks that have reported at least 15% annual revenue growth in the past three years.
The price a stock trades at can drastically impact your overall returns. If you wait for a top growth stock to come down to a ...
GLP-1) receptor agonists, which are used to treat type 2 diabetes and/or obesity, were linked to vision problems in a small study. Here's what doctors have to say.
As drugs like Ozempic and Mounjaro continue to skyrocket in usage, doctors are encountering more cases linking them to ...
Telehealth stock Hims & Hers ( HIMS) spiked more than 24% in trading Thursday, days after its Super Bowl ad promoting cheaper GLP-1 weight-loss drugs sparked controversy.
Now, one type of weight-loss medication is proving helpful with another health issue. In a study published Feb. 12 in JAMA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results